Ty Brender

1.7k total citations
9 papers, 375 citations indexed

About

Ty Brender is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Ty Brender has authored 9 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Oncology and 1 paper in Surgery. Recurrent topics in Ty Brender's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (4 papers). Ty Brender is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (4 papers). Ty Brender collaborates with scholars based in United States, Australia and Switzerland. Ty Brender's co-authors include Yasmin A. Chandrasekher, Patricia A. McKernan, Donald C. Foster, Wenfeng Xu, Cameron S. Brandt, Julia Parrish-Novak, Jim West, Lena Yao, Stephen R. Jaspers and Karla A. Henning and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ty Brender

9 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ty Brender United States 6 259 177 67 61 41 9 375
Melissa Mavers United States 12 285 1.1× 162 0.9× 81 1.2× 105 1.7× 38 0.9× 26 453
Geoffrey A. Smith United States 9 207 0.8× 141 0.8× 57 0.9× 106 1.7× 14 0.3× 9 445
Shengcai Wei China 13 151 0.6× 55 0.3× 45 0.7× 147 2.4× 47 1.1× 20 394
Michael Croft United States 9 324 1.3× 103 0.6× 24 0.4× 101 1.7× 16 0.4× 10 439
Jim West 3 174 0.7× 136 0.8× 10 0.1× 54 0.9× 38 0.9× 4 273
Ioannis Tassiulas United States 9 409 1.6× 149 0.8× 53 0.8× 113 1.9× 16 0.4× 17 564
Miki Ando Japan 12 151 0.6× 233 1.3× 34 0.5× 152 2.5× 40 1.0× 65 453
Orietta D’Orlando Germany 9 322 1.2× 57 0.3× 20 0.3× 98 1.6× 61 1.5× 10 435
Katalin Olasz Hungary 11 185 0.7× 62 0.4× 22 0.3× 93 1.5× 31 0.8× 21 355
Elke Valk United Kingdom 10 378 1.5× 177 1.0× 12 0.2× 79 1.3× 45 1.1× 12 497

Countries citing papers authored by Ty Brender

Since Specialization
Citations

This map shows the geographic impact of Ty Brender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ty Brender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ty Brender more than expected).

Fields of papers citing papers by Ty Brender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ty Brender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ty Brender. The network helps show where Ty Brender may publish in the future.

Co-authorship network of co-authors of Ty Brender

This figure shows the co-authorship network connecting the top 25 collaborators of Ty Brender. A scholar is included among the top collaborators of Ty Brender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ty Brender. Ty Brender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Metz, Heather, Ty Brender, Michael R. Comeau, et al.. (2020). 712 SBT6290, a systemically administered Nectin-4-directed TLR8 ImmunoTAC (TM) therapeutic, is a potent human myeloid cell agonist for the treatment of Nectin-4-expressing tumors. SHILAP Revista de lepidopterología. A427.1–A427. 2 indexed citations
2.
3.
Comeau, Michael R., Ty Brender, Heather Metz, et al.. (2020). Abstract 4537: SBT6050, a HER2-directed TLR8 ImmunoTAC™therapeutic, is a potent human myeloid cell agonist that provides opportunity for single agent clinical activity. Cancer Research. 80(16_Supplement). 4537–4537. 6 indexed citations
4.
Metz, Heather, Ty Brender, Michael R. Comeau, et al.. (2020). SBT6050, a HER2-directed TLR8 therapeutic, as a systemically administered, tumor-targeted human myeloid cell agonist.. Journal of Clinical Oncology. 38(15_suppl). 3110–3110. 26 indexed citations
5.
Moyes, Kara White, Ty Brender, Sean W. Smith, et al.. (2019). Abstract 3271: A systemically administered, conditionally active TLR8 agonist for the treatment of HER2-expressing tumors. Immunology. 3271–3271. 1 indexed citations
6.
Moyes, Kara White, Ty Brender, Sean W. Smith, et al.. (2019). Abstract 3271: A systemically administered, conditionally active TLR8 agonist for the treatment of HER2-expressing tumors. Cancer Research. 79(13_Supplement). 3271–3271. 7 indexed citations
7.
Bezman, Natalie, Ty Brender, Mark Maurer, et al.. (2017). PD-1 blockade enhances elotuzumab efficacy in mouse tumor models. Blood Advances. 1(12). 753–765. 42 indexed citations
8.
Hippen, Keli L., Christoph Bucher, Dawn K. Schirm, et al.. (2011). Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes. Blood. 119(2). 619–628. 59 indexed citations
9.
Parrish-Novak, Julia, Wenfeng Xu, Ty Brender, et al.. (2002). Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes. Journal of Biological Chemistry. 277(49). 47517–47523. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Mavers Breakdown of academic impact, for papers by Geoffrey A. Smith Breakdown of academic impact, for papers by Shengcai Wei Breakdown of academic impact, for papers by Michael Croft Breakdown of academic impact, for papers by Jim West Breakdown of academic impact, for papers by Ioannis Tassiulas Breakdown of academic impact, for papers by Miki Ando Breakdown of academic impact, for papers by Orietta D’Orlando Breakdown of academic impact, for papers by Katalin Olasz Breakdown of academic impact, for papers by Elke Valk
Rankless by CCL
2026